DADATA·ANALYSIS
FREE
company · cik 1472012

Immunome Inc.

IMNMNasdaqSIC 2834public
financials · annual · usd2026
Revenue$6.9M
Net income-$212.4M
Total assets$683.2M
Total liabilities$48.8M
Equity$634.3M
LT debt$134.0K
Operating cash-$190.9M
money-flow · companies

No customer / supplier links anchored.

commodity exposure

No commodity exposure anchored.

places · hq + contracts1